by | Jul 6, 2024 | Publications
Pharmacol Res. 2024 Jul 3:107291. doi: 10.1016/j.phrs.2024.107291. Online ahead of print. ABSTRACT Fibroblast growth factors (FGFs) act as proangiogenic and mitogenic cytokines in several cancers, including multiple myeloma (MM). Indeed, corrupted FGF autocrine and...
by | Jul 6, 2024 | Publications
PET Clin. 2024 Jul 4:S1556-8598(24)00050-6. doi: 10.1016/j.cpet.2024.05.004. Online ahead of print. ABSTRACT According to international guidelines, patients with suspected myeloma should primarily undergo low-dose whole-body computed tomography (CT) for diagnostic...
by | Jul 6, 2024 | Publications
Nat Med. 2024 Jul 5. doi: 10.1038/s41591-024-03171-8. Online ahead of print. NO ABSTRACT PMID:38969881 | DOI:10.1038/s41591-024-03171-8
by | Jul 6, 2024 | Publications
Cell Rep. 2024 Jul 3;43(7):114445. doi: 10.1016/j.celrep.2024.114445. Online ahead of print. ABSTRACT Pro-survival metabolic adaptations to stress in tumorigenesis remain less well defined. We find that multiple myeloma (MM) is unexpectedly dependent on beta-oxidation...
by | Jul 6, 2024 | Publications
Proc Natl Acad Sci U S A. 2024 Jul 9;121(28):e2410959121. doi: 10.1073/pnas.2410959121. Epub 2024 Jul 5. NO ABSTRACT PMID:38968129 | DOI:10.1073/pnas.2410959121
by | Jul 5, 2024 | Publications
Br J Haematol. 2024 Jul 4. doi: 10.1111/bjh.19624. Online ahead of print. ABSTRACT A decade after International Myeloma Working Group (IMWG) biomarkers (SLiM criteria) were introduced, this real-world study examined their impact on diagnosis, therapy and outcomes in...
